Autonomic nervous system function in chronic exogenous subclinical thyrotoxicosis and the effect of restoring euthyroidism

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 7, 2008, Pages 2835-2841

  Eustatia Rutten, Carmen F A ^a   Corssmit, Eleonora P M ^a   Heemstra, Karen A ^a   Smit, Johannes W A ^a   Schoemaker, Rik C ^b   Romijn, Johannes A ^a   Burggraaf, Jacobus ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CENTRE FOR HUMAN DRUG RESEARCH   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DOPA; NORADRENALIN; THYROTROPIN; THYROXINE; VANILMANDELIC ACID;

ADULT; AGED; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; CATECHOLAMINE EXCRETION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; EUTHYROIDISM; FATIGUE; FEMALE; HEADACHE; HEART RATE VARIABILITY; HORMONE SUBSTITUTION; HUMAN; HYPERTHYROIDISM; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SINGLE BLIND PROCEDURE; THYROIDECTOMY; THYROTOXICOSIS; URINARY EXCRETION;

EID: 47549088285     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-0080     Document Type: Article

References (23)

1. Fazio S, Palmieri EA, Lombardi G, Biondi B 2004 Effects of thyroid hormone on the cardiovascular system. Recent Prog Horm Res 59:31-50
2. Klein I 1990 Thyroid hormone and the cardiovascular system. Am J Med 88:631-637
3. Polikar R, Burger AG, Scherrer U, Nicod P 1993 The thyroid and the heart. Circulation 87:1435-1441
4. Levey GS, Klein I 1990 Catecholamine-thyroid hormone interactions and the cardiovascular manifestations of hyperthyroidism. Am J Med 88:642-646
5. Burggraaf J, Tulen JH, Lalezari S, Schoemaker RC, De Meyer PH, Meinders AE, Cohen AF, Pijl H 2001 Sympathovagal imbalance in hyperthyroidism. Am J Physiol Endocrinol Metab 281:E190-E195
6. Cacciatori V, Bellavere F, Pezzarossa A, Dellera A, Gemma ML, Thomaseth K, Castello R, Moghetti P, Muggeo M 1996 Power spectral analysis of heart rate in hyperthyroidism. J Clin Endocrinol Metab 81:2828-2835
7. Chen JL, Chiu HW, Tseng YJ, Chu WC 2006 Hyperthyroidism is characterized by both increased sympathetic and decreased vagal modulation of heart rate: evidence from spectral analysis of heart rate variability. Clin Endocrinol (Oxf) 64:611-616
8. Biondi B, Palmieri EA, Lombardi G, Fazio S 2002 Effects of subclinical thyroid dysfunction on the heart. Ann Intern Med 137:904-914
9. Petretta M, Bonaduce D, Spinelli L, Vicario ML, Nuzzo V, Marciano F, Camuso P, De Sanctis V, Lupoli G 2001 Cardiovascular haemodynamics and cardiac autonomic control in patients with subclinical and overt hyperthyroidism. Eur J Endocrinol 145:691-696
10. Smit JW, Eustatia-Rutten CF, Corssmit EP, Pereira AM, Frolich M, Bleeker GB, Holman ER, van der Wall EE, Romijn JA, Bax JJ 2005 Reversible diastolic dysfunction after long-term exogenous subclinical hyperthyroidism: a randomized, placebo-controlled study. J Clin Endocrinol Metab 90:6041-6047
11. Goichot B, Brandenberger G, Vinzio S, Perrin AE, Geny B, Schlienger JL, Simon C 2004 Sympathovagal response to orthostatism in overt and in subclinical hyperthyroidism. J Endocrinol Invest 27:348-352
12. Portella RB, Pedrosa RC, Coeli CM, Buescu A, Vaisman M 2007 Altered cardiovascular vagal responses in nonelderly female patients with subclinical hyperthyroidism and no apparent cardiovascular disease. Clin Endocrinol (Oxf) 67:290-294
13. Osman F, Franklyn JA, Daykin J, Chowdhary S, Holder RL, Sheppard MC, Gammage MD 2004 Heart rate variability and turbulence in hyperthyroidism before, during, and after treatment. Am J Cardiol 94:465-469
14. 1996 Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J 17:354-381
15. Jern S, Pilhall M, Jern C, Carlsson SG 1991 Short-term reproducibility of a mental arithmetic stress test. Clin Sci (Lond) 81:593-601
16. Hansen AM, Garde AH, Christensen JM, Eller NH, Netterstrom B 2001 Reference intervals and variation for urinary epinephrine, norepinephrine and cortisol in healthy men and women in Denmark. Clin Chem Lab Med 39:842-849
17. Byrne EA, Fleg JL, Vaitkevicius PV, Wright J, Porges SW 1996 Role of aerobic capacity and body mass index in the age-associated decline in heart rate variability. J Appl Physiol 81:743-750
18. Tsuji H, Venditti Jr FJ, Manders ES, Evans JC, Larson MG, Feldman CL, Levy D 1996 Determinants of heart rate variability. J Am Coll Cardiol 28:1539-1546
19. Pfeifer MA, Weinberg CR, Cook D, Best JD, Reenan A, Halter JB 1983 Differential changes of autonomic nervous system function with age in man. Am J Med 75:249-258
20. Mercuro G, Panzuto MG, Bina A, Leo M, Cabula R, Petrini L, Pigliaru F, Mariotti S 2000 Cardiac function, physical exercise capacity, and quality of life during long-term thyrotropin-suppressive therapy with levothyroxine: effect of individual dose tailoring. J Clin Endocrinol Metab 85:159-164
21. Baumgartner H, Wiedermann CJ, Hortnagl H, Muhlberger V 1985 Plasma catecholamines in arterial and capillary blood. Naunyn Schmiedebergs Arch Pharmacol 328:461-463
22. Esler M, Jennings G, Lambert G, Meredith I, Horne M, Eisenhofer G 1990 Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions. Physiol Rev 70:963-985
23. Tulen JH, Man in't Veld AJ, Van Roon AM, Moleman P, Van Steenis HG, Blankestijn PJ, Boomsma F 1994 Spectral analysis of hemodynamics during infusions of epinephrine and norepinephrine in men. J Appl Physiol 76:1914-1921